Perspective

Inflammation, atherosclerosis and hypertension: the impact of depression and stress on their complex relationship

Department of Molecular Medicine, University of Pavia, Pavia, 27100, Italy

Department of Medical & Surgical Sciences for Children & Adults, University of Modena & Reggio Emilia, Modena, 41100, Italy

Search for more papers by this author

Anna Vittoria Mattioli

*Author for correspondence:

E-mail Address: annavittoria.mattioli@unimore.it

https://orcid.org/0000-0003-1487-9530

Department of Medical & Surgical Sciences for Children & Adults, University of Modena & Reggio Emilia, Modena, 41100, Italy

Search for more papers by this author

Published Online:21 Dec 2023https://doi.org/10.2217/fca-2023-0030

View article

Abstract

This future perspective analyzes the complex relationship between inflammation and atherosclerosis and arterial hypertension. The involvement of inflammation in atherosclerosis has led to research therapies that target inflammation to prevent or treat cardiovascular disease. This aspect has recently been included in the treatment management of residual cardiovascular risk. The recent pandemic has exacerbated cardiovascular risk both through an increase in unhealthy lifestyle behaviors and through the reduction of cardiovascular screening. What actions to take? Primary prevention campaigns for healthy subjects with specific attention to young people.

Plain language summary

What is this article talking about? This article talks about how inflammation, atherosclerosis (a condition where arteries get narrow), and high blood pressure are connected. It looks deeply into how these things work together and can lead to heart problems. What is the point of the study? Learning about how inflammation is linked to atherosclerosis has made scientists study new ways to treat or prevent heart diseases. This is now a part of how we think about treating the risk of heart problems. How can we check the risk of heart problems in women? To make the risk of heart problems less, it's really important to start looking at and dealing with things that might cause these problems early on. Pregnancy is a good time to start doing this for young women. What changed because of the pandemic? The pandemic made it harder to prevent heart problems, and it made people more stressed. Women, especially, faced more challenges during and after the pandemic in terms of society and money.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Bkaily G, Jacques D. Morphological and functional remodeling of vascular endothelium in cardiovascular diseases. Int. J. Mol. Sci. J. 24(3), 1998 (2023).
Medline CASGoogle Scholar
2. Sachse M, Tual-Chalot S, Ciliberti G et al. RNA-binding proteins in vascular inflammation and atherosclerosis. Atherosclerosis S0021-9150(23), 00009-6 (2023).
MedlineGoogle Scholar
3. Bauer R, Brüne B, Schmid T. Cholesterol metabolism in the regulation of inflammatory responses. Front. Pharmacol. 14, 1121819 (2023).
Medline CASGoogle Scholar
4. Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. Int. J. Mol. Sci. 23(21), 12906 (2022).
MedlineGoogle Scholar
5. D'Ascenzi F, Sciaccaluga C, Cameli M et al. When should cardiovascular prevention begin? The importance of antenatal, perinatal and primordial prevention. Eur. J. Prev. Cardiol. 2047487319893832 (2019).
Google Scholar
6. Taghizadeh E, Taheri F, Renani PG, Reiner Ž, Navashenaq JG, Sahebkar A. Macrophage: a key therapeutic target in atherosclerosis? Curr. Pharm. Des. 25(29), 3165–3174 (2019).
Medline CASGoogle Scholar
7. Ciccarelli G, Conte S, Cimmino G, Maiorano P, Morrione A, Giordano A. Mitochondrial dysfunction: the hidden player in the pathogenesis of atherosclerosis? Int. J. Mol. Sci. 24(2), 1086 (2023).
Medline CASGoogle Scholar
8. Guo X, Ma L. Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. Coron. Artery Dis. 34(1), 66–77 (2023).
MedlineGoogle Scholar
9. Frąk W, Wojtasińska A, Lisińska W, Młynarska E, Franczyk B, Rysz J. Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines 10(8), 1938 (2022).
Medline CASGoogle Scholar
10. Ajala ON, Demler OV, Liu Y et al. Anti-inflammatory HDL function, incident cardiovascular events, and mortality: a secondary analysis of the JUPITER randomized clinical trial. J. Am. Heart Assoc. 9(17), e016507 (2020).
Medline CASGoogle Scholar
11. Ridker PM, Danielson E, Fonseca FA et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373, 1175–1182 (2009).
Medline CASGoogle Scholar
12. Nurmohamed N, Naver A, Kastelein J. New and emerging therapies for reduction of LDL cholesterol and apolipoprotein B: JACC focus seminar. J. Am. Coll. Cardiol. 77, 1564–1575 (2021).
Medline CASGoogle Scholar
13. Ridker P, Bhatt D, Pradhan A et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomized trials. Lancet 401, 1293–1301 (2023).
Medline CASGoogle Scholar
14. Nelson K, Fuster V, Ridker PM. Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week. J. Am. Coll. Cardiol. 82(7), 648–660 (2023).
Medline CASGoogle Scholar
15. Kumar D, Pandit R, Yurdagul A Jr. Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism 5(1), e00017 (2023).
MedlineGoogle Scholar
16. Zanini G, Selleri V, Lopez Domenech S et al. Mitochondrial DNA as inflammatory DAMP: a warning of an aging immune system? Biochem. Soc. Trans. 51(2), 735–745 (2023).
Medline CASGoogle Scholar
17. Kiełbowski K, Bakinowska E, Pawlik A. The potential role of connexins in the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 24(3), 2600 (2023).
Medline CASGoogle Scholar
18. An J, Zhang Y, Zhou H et al. Incidence of atherosclerotic cardiovascular disease in young adults at low short-term but high long-term risk. J. Am. Coll. Cardiol. 81(7), 623–632 (2023).
MedlineGoogle Scholar
19. Cimmino G, Muscoli S, De Rosa S et al. Evolving concepts in the pathophysiology of atherosclerosis: from endothelial dysfunction to thrombus formation through multiple shades of inflammation. J. Cardiovasc. Med. (Hagerstown) 24(Suppl. 2), e156–e167 (2023).
MedlineGoogle Scholar
20. Ferdinandy P, Andreadou I, Baxter GF et al. Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning. Pharmacol. Rev. 75(1), 159–216 (2023).
Medline CASGoogle Scholar
21. Mattioli AV, Moscucci F, Sciomer S et al. Cardiovascular prevention in women: un update By the Italian Society of Cardiology Working Group On “Prevention, hypertension and peripheral disease”. J. Cardiovasc. Med. (Hagerstown) 24(Suppl. 2), e147–e155 (2023).
MedlineGoogle Scholar
22. Luo C, Ruan Y, Sun P et al. The role of transcription factors in coronary artery disease and myocardial infarction. Front. Biosci. (Landmark Ed). 27(12), 329 (2022).
Medline CASGoogle Scholar
23. Shuvalova YA, Kaminnaya V, Kaminnyi AI. Contribution of Interleukin-6 system genes polymorphisms to the development of coronary atherosclerosis. Gene 861, 147253 (2023).
Medline CASGoogle Scholar
24. Batty M, Bennett MR, Yu E. The role of oxidative stress in atherosclerosis. Cells 11(23), 3843 (2022).
Medline CASGoogle Scholar
25. Zhang Z, Zhao L, Zhou X, Meng X, Zhou X. Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front. Immunol. 13, 1098725 (2023).
MedlineGoogle Scholar
26. Mattioli AV, Coppi F, Bucciarelli V, Gallina S. Cardiovascular risk stratification in young women: the pivotal role of pregnancy. J. Cardiovasc. Med. (Hagerstown) 24(11), 793–797 (2023).
MedlineGoogle Scholar
27. Cadeddu C, Franconi F, Cassisa L et al. Arterial hypertension in the female world: pathophysiology and therapy. J. Cardiovasc. Med. (Hagerstown) 17(4), 229–236 (2016).
Medline CASGoogle Scholar
28. Cameli M, Lembo M, Sciaccaluga C et al. Identification of cardiac organ damage in arterial hypertension: insights by echocardiography for a comprehensive assessment. J. Hypertens. 38(4), 588–598 (2020).
Medline CASGoogle Scholar
29. Harsanyi S, Kupcova I, Danisovic L, Klein M. Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int. J. Mol. Sci. 24(1), 578 (2022).
MedlineGoogle Scholar
30. Mattioli AV, Coppi F, Nasi M, Gallina S. Stress and cardiovascular risk burden after the pandemic: current status and future prospects. Expert. Rev. Cardiovasc. Ther. 20(7), 507–513 (2022).
Medline CASGoogle Scholar
31. Liu ST, Lin SC, Chang JP et al. The clinical observation of inflammation theory for depression: the initiative of the Formosa Long COVID Multicenter Study (FOCuS). Clin. Psychopharmacol. Neurosci. 21(1), 10–18 (2023).
MedlineGoogle Scholar
32. Simon MS, Arteaga-Henríquez G, Fouad Algendy A, Siepmann T, Illigens BMW. Anti-Inflammatory treatment efficacy in major depressive disorder: a systematic review of meta-analyses. Neuropsychiatr. Dis. Treat. 19, 1–25 (2023).
Medline CASGoogle Scholar
33. Silverman AL, Herzog AA, Silverman DI. Hearts and minds: stress, anxiety, and depression: unsung risk factors for cardiovascular disease. Cardiol. Rev. 27(4), 202–207 (2019).
MedlineGoogle Scholar
34. Lu S, Wei F, Li G. The evolution of the concept of stress and the framework of the stress system. Cell Stress 5(6), 76–85 (2021).
MedlineGoogle Scholar
35. Popovic D, Popovic B, Plecas-Solarovic B et al. The interface of hypothalamic-pituitaryadrenocortical axis and circulating brain natriuretic peptide in prediction of cardiopulmonary performance during physical stress. Peptides 47, 85–93 (2013).
Medline CASGoogle Scholar
36. Goldstein BI, Carnethon MR, Matthews KA et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation 132, 965–986 (2015).
MedlineGoogle Scholar
37. Lichtman JH, Froelicher ES, Blumenthal JA et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129, 1350–1369 (2014).
MedlineGoogle Scholar
38. Cocchi C, Coppi F, Farinetti A, Mattioli AV. Cardiovascular disease prevention and therapy in women with Type 2 diabetes. Future Cardiol. 17(3), 487–496 (2021).
CASGoogle Scholar
39. Stein M. Stress, depression, and the immune system. J. Clin. Psychiatry 50(Suppl. 35–40), 41–42 (1989).
Google Scholar
40. Kivimaki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol. 15, 215–229 (2018).
Medline CASGoogle Scholar
41. García-Lara RA, Suleiman-Martos N, Membrive-Jiménez MJ et al. Prevalence of depression and related factors among patients with chronic disease during the COVID-19 pandemic: a systematic review and meta-analysis. Diagnostics (Basel) 12(12), 3094 (2022).
MedlineGoogle Scholar
42. Tsai FJ, Shen SW. Concepts of dementia prevention in the health promotion among older adults: a narrative review. Medicine (Baltimore) 101(50), e3212 (2022).
Google Scholar
43. Mattioli AV, Selleri V, Zanini G et al. Physical activity and diet in older women: a narrative review. J. Clin. Med. 12, 81 (2023).
CASGoogle Scholar
44. Rickles NM, Sharma M, Harrow S, Silverwatch J. A narrative review: pharmacy intervention fidelity. J. Am. Pharm. Assoc. S1544-3191(22)00355-7 (2022).
Google Scholar
45. Vogel B, Acevedo M, Appelman Y et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 397(10292), 2385–2438 (2021).
MedlineGoogle Scholar
46. Mattioli AV, Nasi M, Cocchi C, Farinetti A. COVID 19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden. Future Cardiol. 16(6), 539–542 (2020). •• A comprehensive review of the effects of stress on cardiovascular risk.
CASGoogle Scholar
47. Almeida M, Shrestha AD, Stojanac D, Miller LJ. The impact of the COVID-19 pandemic on women's mental health. Arch. Womens Ment. Health 23(6), 741–748 (2020).
MedlineGoogle Scholar
48. Azizi Z, Alipour P, Raparelli V, Norris CM, Pilote L. The role of sex and gender in hypertension. J. Hum. Hypertens. 37(8), 589–595 (2023).
MedlineGoogle Scholar
49. Coppi F, Nasi M, Farinetti A et al. Physical activity, sedentary behaviour, and diet in menopausal women: comparison between COVID19 “first wave” and “second wave” of pandemic in Italy. Progress Nutrition 23(2), 11755 (2021).
Google Scholar
50. Kabra A, Garg R, Brimson J et al. Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Front. Pharmacol. 13, 1046599 (2022).
Medline CASGoogle Scholar
51. Truzzi ML, Ballerini Puviani M, Tripodi A et al. Mediterranean diet as a model of sustainable, resilient and healthy diet. Progr. Nutr. 22, 388–394 (2020).
Google Scholar
52. Mahajan A, Bandaru D, Parikh K, Gupta V, Patel M. From the inside out: understanding the gut–heart connection. Future Cardiol. 19(10), 505–514 (2023). • Interesting review on a new cardiovascular risk factor.
CASGoogle Scholar
53. Mattioli AV, Migaldi M, Farinetti A. Coffee in hypertensive women with asymptomatic peripheral arterial disease: a potential nutraceutical effect. J. Cardiovasc. Med. (Hagerstown) 19(4), 183–185 (2018).
MedlineGoogle Scholar
54. Jumar A, Schmieder RE. Cocoa flavanol cardiovascular effects beyond blood pressure reduction. J. Clin. Hypertens. (Greenwich) 18, 352–358 (2016).
Medline CASGoogle Scholar
55. Begdache L, Sadeghzadeh S, Derose G, Abrams C. Diet, exercise, lifestyle, and mental distress among young and mature men and women: a repeated cross-sectional study. Nutrients 13(1), 24 (2020).
MedlineGoogle Scholar
56. Torres SJ, Nowson CA. Relationship between stress, eating behavior, and obesity. Nutrition 23(11–12), 887–894 (2007).
MedlineGoogle Scholar

Vol. 20, No. 1

Metrics

Downloaded 90 times

History

Received 21 February 2023

Accepted 28 November 2023

Published online 21 December 2023

Published in print January 2024

Information

Keywords

Author contributions

MM Coronelli conceived of the idea at the basis of the article, AV Mattioli, F Coppi and MM Coronelli developed the different part of the manuscript and performed the final supervision. All authors contributed to and approved the final manuscript.

Acknowledgments

We thank M Blondell and R Pescatori for the support provided.

Financial disclosure

The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

PDF download